Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

NCT06924359 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06924359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06924359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2025
Completion date
August 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad)